JTC Team to Host the Virtual Investor 2023 Companies to Watch Event on January 17th, 18th, and 19th
Moleculin Biotech, Inc. (MBRX)
Last moleculin biotech, inc. earnings: 8/16 05:35 pm
Check Earnings Report
US:NASDAQ Investor Relations:
moleculin.com/investors
Company Research
Source: Accesswire
- Live video webcast presentations with participating companies -FRENCHTOWN, NJ / ACCESSWIRE / January 11, 2023 / JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today announced it will host the Virtual Investor 2023 Companies to Watch Event, January 17-19, 2023. As part of the virtual event, participating companies will provide a corporate presentation.The schedule for the event is as follows:Tuesday, January 17, 20239:00 AM ET: Moleculin Biotech, Inc. (Nasdaq:MBRX) - WEBCAST10:00 AM ET: Xenetic Biosciences, Inc. (Nasdaq:XBIO) - WEBCAST11:00 AM ET: Outlook Therapeutics, Inc. (Nasdaq:OTLK) - WEBCAST1:00 PM ET: Vallon Pharmaceuticals, Inc. (Nasdaq:VLON)/GRI Bio (Private) - WEBCAST2:00 PM ET: Novan, Inc. (Nasdaq:NOVN) - WEBCAST3:00 PM ET: Palisade Bio, Inc. (Nasdaq:PALI) - WEBCAST4:00 PM ET: American Resources Corporation (Nasdaq:AREC) - WEBCASTWednesday, January 18, 202310:00 AM ET: CNS Pharmaceuticals Inc. (Nasdaq:CNSP) - WEBCAST11:00 AM ET:A
Show less
Read more
Impact Snapshot
Event Time:
MBRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MBRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MBRX alerts
High impacting Moleculin Biotech, Inc. news events
Weekly update
A roundup of the hottest topics
MBRX
News
- Moleculin Biotech, Inc. (NASDAQ: MBRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- European Medicines Agency (EMA) Grants Orphan Drug Designation for Moleculin's Treatment of Acute Myeloid Leukemia (AML) [Yahoo! Finance]Yahoo! Finance
- European Medicines Agency (EMA) Grants Orphan Drug Designation for Moleculin's Treatment of Acute Myeloid Leukemia (AML)PR Newswire
- Moleculin Biotech, Inc. (NASDAQ: MBRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Moleculin Biotech, Inc. (NASDAQ: MBRX) had its "buy" rating re-affirmed by analysts at Roth Mkm. They now have a $40.00 price target on the stock.MarketBeat
MBRX
Analyst Actions
- 3/26/24 - Maxim Group
MBRX
Sec Filings
- 4/18/24 - Form 8-K
- 4/10/24 - Form 8-K
- 4/8/24 - Form 8-K
- MBRX's page on the SEC website